© 1999 American Heart Association, Inc.
Original Contributions |
Possible Induction of Renal Dysfunction in Patients With Lecithin:Cholesterol Acyltransferase Deficiency by Oxidized Phosphatidylcholine in Glomeruli
From the Departments of Pathology (S.J., N.U., S.T.) and Internal Medicine (K.S., B.Z., K.A.), Fukuoka University School of Medicine, Fukuoka, and the Department of Microbiology and Molecular Pathology (H.I.), Teikyo University Faculty of Pharmaceutical Sciences, Kanagawa, Japan.
Correspondence to Dr Shigeo Takebayashi, Second Department of Pathology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonanku, Fukuoka 814-80, Japan. E-mail mm036938{at}msat.fukuoka-u.ac.jp
Abstract—To clarify the causes of renal dysfunction in familial lecithin:cholesterol acyltransferase (LCAT) deficiency, kidney samples from 4 patients with LCAT deficiency (3 homozygotes and 1 heterozygote) were examined immunohistochemically. All of the patients exhibited corneal opacities, anemia, renal dysfunction, deficiencies in plasma high density lipoprotein and LCAT activity and mass, and an increase in the ratio of plasma unesterified cholesterol to esterified cholesterol. Renal lesions began with the deposition of lipidlike structures in the glomerular basement membrane, and these structures accumulated in the mesangium and capillary subendothelium. By electron microscopy, 2 types of distinctive structure were found in glomerular lesions: vacuole structures and cross-striated, membranelike structures. The plasma oxidized phosphatidylcholine (oxPC) –modified low density lipoprotein (LDL) levels in LCAT-deficient subjects were significantly (P<0.01) higher than those in controls (1.30±0.82 versus 0.42±0.32 ng/5 µg LDL, respectively), and a significant (P<0.01) difference was observed even after adjustment for confounding factors by an analysis of covariance. The patient with the highest plasma oxPC-modified LDL had the most membranelike structures in the glomeruli and showed the greatest renal deterioration from a young age. In glomerular lesions, although there was an abundance of apoB and apoE, oil red O–positive lipids, macrophages, apoA1, and malondialdehyde were scarce. OxPC was found extracellularly in glomerular lesions, and although its distribution differed from that of apolipoproteins, it was quite similar to that of phospholipids. In conclusion, these results indicate that oxPC in plasma and glomeruli is distinctive for patients with LCAT deficiency. Therefore, oxPC may be a factor in the deterioration of kidneys in patients with familial LCAT deficiency.
Key Words: lecithin:cholesterol acyltransferase deficiency • oxidized phosphatidylcholine • modified LDL • kidney
This article has been cited by other articles:
 |
|
 |
|
  G. M. Frasca, L. Soverini, E. Tampieri, G. Franceschini, L. Calabresi, L. Pisciotta, P. Preda, A. Vangelista, S. Stefoni, and S. Bertolini A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1622 - 1624. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mori, H. Itabe, Y. Higashi, Y. Fujimoto, M. Shiomi, M. Yoshizumi, Y. Ouchi, and T. Takano Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum J. Lipid Res., November 1, 2001; 42(11): 1771 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lambert, N. Sakai, B. L. Vaisman, E. B. Neufeld, B. Marteyn, C.-C. Chan, B. Paigen, E. Lupia, A. Thomas, L. J. Striker, et al. Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice J. Biol. Chem., April 27, 2001; 276(18): 15090 - 15098. [Abstract] [Full Text] [PDF]
|
|